Announcements Trials
Browse Landscape

Status

Unknown 3Completed 2

Sponsor Class

OTHER 5

Study Type

Interventional 10Observational 5

Sponsor

Cancer Type

Gynecologic 3Tumor-Agnostic 2

Conditions

Ovarian Neoplasms 3Neoplasms 2Kenny-Caffey syndrome, Type 1 1

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 406Surgical Procedures, Operative 151Radiotherapy 131Interviews as Topic 131Drug Therapy 123Observation 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 59Watchful Waiting 52Immunotherapy 51Bevacizumab 50Positron Emission Tomography Computed Tomography 46Ultrasonography 44Hematologic Tests 42Liquid Biopsy 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Observational × Poly(ADP-ribose) Polymerase Inhibitors × Clear all
NCT04724031 2023-03-14

Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer

Hellenic Cooperative Oncology Group

Unknown
150 enrolled
Gynecologic

Ovarian Neoplasms

NCT04774627 2021-09-23

Pancytopenia Related to PARP Inhibitors (PancytoRIB)

University Hospital, Caen

Completed
200 enrolled
Tumor-Agnostic

Neoplasms

NCT05044091 2021-09-14

HOPEI

Jiangsu Cancer Institute & Hospital

Unknown
100 enrolled
Gynecologic

Kenny-Caffey syndrome, Type 1, Ovarian Neoplasms

NCT04326023 2021-03-11

Myelodysplastic Syndrome and Acute Myeloid Leukemia Related to PARP Inhibitors (MyeloRIB)

University Hospital, Caen

Completed
178 enrolled
Tumor-Agnostic

Neoplasms

NCT04582552 2021-01-20

ROMP

Jiangsu Cancer Institute & Hospital

Unknown
60 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡